• 제목/요약/키워드: Total surgical resection

검색결과 340건 처리시간 0.03초

수술후성 기관협착증에 관한 임사적 고찰 (The clinical study for the postoperative tracheal stenosis)

  • 김기령;홍원표;이정권
    • 대한기관식도과학회:학술대회논문집
    • /
    • 대한기관식도과학회 1977년도 제11차 학술대회연제 순서 및 초록
    • /
    • pp.9.1-10
    • /
    • 1977
  • 문명의 발달로 나날히 복잡해지는 사회 환경속에서 우리는 생명을 위협하는 수 많은 사고를 당하게 되며, 이럭 경우에 상기도를 유지하기 위한 기관절재술을 많이 시행하게 되는데, 때로는 기관협착등 이에 따른 여러가지 합병증을 유발하게 되는 경우가 있으며, 임상가들에게도 곤란한 문제를 갖어다 주고있다. 그러나 이러한 합병증은 수술방법의 개선과 항생제의 출현등으로 그 빈도가 많이 감소되기는 하였으나, 1969년 Lindholm은 술후성 기관협착증의 빈도를 1.5%내지 10%라고 했으며, 1969년 Donnelly, Mulder와 Rubush, 그리고 1971년 Andrew와 Pearson 등은 이들 원인의 대부분이 cuff 가 있는 기관삽입관이나, 기관케뉼(tracheal canula)의 부적합한 사용이나, 또는 감염에 의한 압박괴사(pressure necrosis)로 형성된다고 하였고, 협착부위로서 1972년 Bryce는 절개공(stoma)주위가 가장 많으며, 응급기관절개술시에 의사의 부정요법(mal-practice)도 원인이 될 수 있다고도 주의한 바 있다. 기관협착증의 치료로서 협착이 경미한 경우에는 일차적으로 세심한 관찰을 실시하면서 실리콘관(silicon tube)이나 스텐트(stent)를 사용하거나, 비강을 통한 삽관법(naso tracheal intubation)으로 기계적인 확장을 시도하며 (Schmiegelow, 1929, Montgomery, 1965), 육아조직이 형성되었을 경우에는 기관경검사하에서 이를 제거한 후에 steroid를 병용하는 편이 좋은데(Birck, 1970) 그밖에도 기관개찰술(Fenestration method, 백·홍 1974)이나 재수술(Revision)을 하기도 한다. 이러한 방법으로서도 치료가 불가능한 경우에는 그 협착 부분을 절제한 후에 단단문합술(End-to-End Anasto-mosis)을 시행하는 수도 있다. 저자들은 1967년 10월부터 1977년 3월까지 10연년간 세브란스병원에서 기관절개술을 받았던 1514례를 대상으로 일련의 조사를 실시하여 이들 중에서 기관협착증을 유발한 23례를 치료하였으며, 여기서 몇가지 지견을 얻었기에 보고하는 바이다.

  • PDF

Regional Lymph Node Dissection as an Additional Treatment Option to Endoscopic Resection for Expanded Indications in Gastric Cancer: a Prospective Cohort Study

  • Seo, Ho Seok;Yoo, Han Mo;Jung, Yoon Ju;Lee, Sung Hak;Park, Jae Myung;Song, Kyo Young;Jung, Eun Sun;Choi, Myung-Gyu;Park, Cho Hyun
    • Journal of Gastric Cancer
    • /
    • 제20권4호
    • /
    • pp.442-453
    • /
    • 2020
  • Purpose: Expanded indications for endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) remain controversial due to the potential risk of undertreatment after adequate lymph node dissection (LND). Regional LND (RLND) is a novel technique used for limited lymphadenectomy to avoid gastrectomy. This study established the safety and effectiveness of RNLD as an additional treatment option after ESD for expanded indications. Materials and Methods: A total of 69 patients who met the expanded indications for ESD were prospectively enrolled from 2014 to 2017. The tumors were localized using intraoperative esophagogastroduodenoscopy (EGD) before RLND. All patients underwent RLND first, followed by conventional radical gastrectomy with LND. The locations of the preoperative and intraoperative EGD were compared. Pathologic findings of the primary lesion and the RLND status were analyzed. Results: The concordance rates of tumor location between the preoperative and intraoperative EGD were 79.7%, 76.8%, and 63.8% according to the longitudinal, circumferential, and regional locations, respectively. Of the 4 patients (5.7%) with metastatic LNs, 3 were pathologically classified as beyond the expanded indication for ESD and 1 had a single LN metastasis in the regional lymph node. Conclusions: RLND is a safe additional option for the treatment of EGC in patients meeting expanded indications after ESD.

악성흑색종 환자군에서 수술적 치료 후 시행한 고용량 인터페론-${\alpha}2b$ 면역요법에 의한 보조적 치료 결과 분석: 예비보고 (The Analysis of Post Operative Treatment of Malignant Melanoma Using High Dose Interferon-${\alpha}2b$ Immunotherapy: Preliminary Report)

  • 정소학;조현익
    • 대한골관절종양학회지
    • /
    • 제18권2호
    • /
    • pp.78-82
    • /
    • 2012
  • 목적: 고용량 인터페론-${\alpha}2b$를 이용한 악성흑색종의 면역요법은 외과적 절제술 후 현미경적 적이나 남아있는 종양의 재발을 막고 무병생존율과 전체 생존율을 높이는 것으로 알려져 있다. 저자 등은 악성 흑색종 환자군에서 외과적 절제술 후 고용량 인터페론-${\alpha}$ 면역요법을 시행한 그룹의 무병생존기간 및 전체 생존율 등을 비교 분석하여 면역요법의 치료결과를 예비 보고하고자 한다. 대상 및 방법: 2010년 2월부터 2012년 10월까지 본원에서 악성 흑색종으로 진단받고 외과적 수술 후 면역치료를 시행한 5명을 대상으로 분석 하였다. 병기는 AJCC 병기를 이용하여 판정하였으며 IIA 3예, IIB 1예, IV 1예로 나타났다. 추시기간은 최소 7개월에서 최대 32개월이었다. 면역 요법을 시행한 군에서는 먼저 유도요법으로 ${\alpha}2b$를 체표면적 당 20만 IU를 총 4주간 1주일에 5회 정주하였으며 이후 유지요법으로 체표면적당 10만 IU를 총 48주간 1주일에 3회 피하주사하였다. 이들 환자들에 대해 국소재발과 국소전이, 그리고 원격전이여부를 조사하였고 무병생존기간을 조사하였다. 결과: 인터페론-${\alpha}2b$ 면역요법을 시행한 환자군에서 추시 흉부 전산화 단층촬영 및 양전자 컴퓨터 단층촬영을 통한 평가 결과 현재까지 모두 국소 재발 및 국소전이 원격전이의 증거가 없는 것으로 나타났다. 결론: 고용량 인터페론-${\alpha}$ 면역요법 시행군에서 현재까지 종양의 국소 재발 및 전이를 막는 것으로 나타났으나 향후 궁극적인 생존율 및 무병생존율 향상이 달성되는가에 대해서는 추가적인 연구대상과 추적관찰이 필요하겠다.

종격동 신생물의 수술적 치료 (Surgical Treatment of Mediastinal Neoplasms)

  • 박경택;류지윤;김연수;김창영;장우익
    • 대한기관식도과학회지
    • /
    • 제13권2호
    • /
    • pp.34-39
    • /
    • 2007
  • Background: The mediastinum is the anatomic space which is restricted and the clinical aspect varies according to location, size and type of neoplasm. Diagnostic and therapeutic approaches to mediastinal neoplasms have changed over and over. We presented our recent therapeutic experiences with these neoplasms. The object and method: The 36 patients were treated in operation from 2000 until 2006. The male patients were 20 and the female patients were 16. Age of the patients ranged from 5 to 70, and the median age was $46.4{\pm}21.9$. The child patients were two. Result: The most prevalent anatomic distribution of the neoplasm was anterosuperior mediastinum. The most common neoplasm was thymoma, followed by thymic cyst, teratoma, ganglioneuroma. The complete excison of neoplasm was accomplished in 96% of patient group except thymoma patient group. One patient underwent total thymectomy, and the other 12 patients underwent extended thymectomy from 13 thymoma patient group. In the malignant neoplasm, 7 patients were received additional treatment after operation. There was short-term death of 1 person and late death of 1 person. Conclusion: Our results except clinical manifestation are compared favorably with other reports. Surgery is the management of choice for patients with mediastinal neoplasm and early curative resection is considered to optimize clinical outcome for patients.

  • PDF

Post-operative Treatment with Cisplatin and Vinorelbine in Chinese Patients with Non-small Cell Lung Cancer: A Clinical Prospective Analysis of 451 Patients

  • Wang, Jing;Liu, Feng;Huang, Deng-Xiao;Jiang, Bin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권9호
    • /
    • pp.4505-4510
    • /
    • 2012
  • Purpose: To determine the efficacy of post-operative chemotherapy with cisplatin plus vinorelbine (NP) in Chinese patients with non-small cell lung cancer (NSCLC). Methods: A total of 451 patients with NSCLCs at stages I, II, and IIIA after surgical resection were treated with cisplatin plus vinorelbine for 4 cycles or volunteers observed between January 2002 and November 2004 and were followed for five years. The therapeutic efficacy was evaluated with reference to overall survival (OS) and disease-free survival (DFS), and adverse effects were also recorded. Potential factors affecting the lengths of OS and DFS were analyzed by multivariate analysis. Results: Most patients (86.7%) completed at least 4 cycles of treatment. Patients with chemotherapy survived significantly longer than those in the observation group (p<0.001). The absolute improvements in the 2 and 5-year OS were 3.8% [hazard ratio (HR) =0.674, 95% confidence interval (CI): 0.554-0.820, P<0.0001] and 13.0% (HR=0.732, 95% CI: 0.579-0.926, P=0.009), respectively. The improvement at 4-year DFS was 2.1% (HR=0.327, 95% CI: 0.214-0.500, P<0.0001). Stratification analysis revealed that older age, histological type, pathological degree, but not the gender and smoking status, are independent factors affecting the length of survival in this population. Many patients (63.3%) had grade 1-III tolerable adverse effects, and there was no treatment-related death. Conclusions: Post-operative chemotherapy with NP regimen is effective and tolerable in Chinese patients with NSCLC.

Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome

  • Park, Hye Jung;Cha, Yoon-Jin;Kim, Seong Han;Kim, Arum;Kim, Eun Young;Chang, Yoon Soo
    • Tuberculosis and Respiratory Diseases
    • /
    • 제80권2호
    • /
    • pp.179-186
    • /
    • 2017
  • Background: Although the World Health Organization (WHO) classification of lung squamous cell carcinoma (SCC) was revised in 2015, its clinical implications for lung SCC subsets remain unclear. We investigated whether the morphologic characteristics of lung SCC, including keratinization, were associated with clinical parameters and clinical outcome of patients. Methods: A total of 81 patients who underwent curative surgical resection of diagnosed lung SCC, were enrolled in this study. Attributes such as keratinization, tumor budding, single cell invasion, and nuclear size within the tumor, as well as immunohistochemistry of Bcl-xL and pS6 expressions, were evaluated. Results: The keratinizing and nonkeratinizing subtypes did not differ with respect to age, sex, TNM stage, and morphologic parameters such as nuclear diameter, tumor budding, and single cell invasion at the tumor edge. Most patients with the keratinizing subtype (98.0%) had a history of smoking, whereas the nonkeratinizing group had a relatively higher proportion of never-smokers relative to the keratinizing group (24.0% vs. 2.0%; p=0.008, chi-square test). Expression of pS6 (a surrogate marker of mammalian target of rapamycin complex 1 [mTORC1] signaling that regulates keratinocyte differentiation), and Bcl-xL (a key anti-apoptotic molecule that may inhibit keratinization), did not correlate significantly with the presence of keratinization. Patients with the keratinizing subtype had a significantly shorter overall survival (85.2 months vs. 135.7 months, p=0.010, log-rank test), and a multivariate analysis showed that keratinization was an independent, poor prognostic factor (hazard ratio, 2.389; 95% confidence interval, 1.090-5.233; p=0.030). Conclusion: In lung SCC, keratinization is associated with a poor prognosis, and might be associated with smoking.

구강 내 접근법에 의한 심부 악하선 타석제거술 (Transoral removal of proximal submandibular stone: report of 5 cases and review of the literature)

  • 임경민;이승준;길태준;최은주;김형준;차인호;남웅
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제36권6호
    • /
    • pp.548-552
    • /
    • 2010
  • The submandibular gland is the second largest major salivary gland, which secretes 40% of the total daily saliva. Owing to its anatomic characteristics as well as the high viscosity and basicity of the saliva, sialolithiasis is found most commonly in the submandibular gland. Sialolithiasis that cannot be treated by conservative treatment is conventionally removed by an excision of the submandibular gland. Generally, an excision of the submandibular gland is performed via an extra-oral approach but the disadvantages of this treatment include a risk of injuring the facial nerve and scar formation. Case reports have revealed an even less invasive intraoral surgical technique for the removal of sialolith that does not affect the submandibular gland function. The functional recovery of the gland, complications and recurrence rates after surgery with this conservative intraoral procedure were all successful. We report 5 patients from the department of Oral and Maxillofacial Surgery at Dental Hospital, Yonsei University, who had undergone a resection of the sialolith though the intraoral approach with successful results.

폐색전증으로 오인된 폐동맥내막육종 1예 (A Case of Pulmonary Artery Intimal Sarcoma Masquerading as Pulmonary Embolism)

  • 김진숙;박혜경;이혜란;강승대;배상철;김수영;장선희;장우익;강승희;이성순
    • Tuberculosis and Respiratory Diseases
    • /
    • 제72권2호
    • /
    • pp.218-222
    • /
    • 2012
  • Pulmonary artery intimal sarcoma is a rare tumor with no characteristic symptoms. It is frequently misdiagnosed as pulmonary embolism. We report a case of pulmonary artery intimal sarcoma in a 48-year-old man with dyspnea, cough and blood-tinged sputum. He was initially suspected and treated as a pulmonary embolism. Computed tomography of the chest showed filling defects occupying the entire luminal diameter of the right and left pulmonary artery as well as extraluminal extension of the intraluminal mass. Surgical resection of the tumor confirmed pulmonary artery intimal sarcoma. After surgery, he received 8 cycles of combined chemotherapy consisting of doxorubicin and ifosfamide. After 8 cycles, Computed tomography of the chest showed interval regression of the residual tumor. Radiotherapy was done as total 6,000 cGy for 5 weeks, following the 8th chemotherapy. The patient's condition was successfully stabilized with chemotherapy and radiotherapy.

갑상선의 세침흡인 세포학적 오진에 대한 세포병리학적 분석 (Cytopathologic Analysis on Fine Needle Aspiration Cytologic Misdiagnoses of the Thyroid)

  • 박찬필;금주섭;이원미;박문향;이중달
    • 대한세포병리학회지
    • /
    • 제9권2호
    • /
    • pp.169-180
    • /
    • 1998
  • Fine needle aspiration cytology(FNAC) has been used effectively as the initial modality in evaluating various thyroid lesions. We correlated cytologic and histopathologic features to investigate the diagnostic pitfalls of FNAC of the thyroid. A total of 1,593 FNACs of the thyroid were diagnosed at the Department of Pathology, Hanyang University Hospital, from January 1993 to December 1997 There were 963 cytologically benign cases(60.5%), 97 suspicious cases(6.1%), and 75 malignant cases(4.71%). The remaining 458 cases(28.8%) were unsatisfactory. Subsequent surgical resection was done in 192 cases. Seventy-two cases(37.5%) were cytologically diagnosed as benign, 45 cases(23.4%) suspicious, 56 cases(29.2%) malignant, and 19 cases(9.9%) unsatisfactory. Histopathologically, 101 cases were benign(11 thyroidites, 52 adenomatous hyperplasias, 34 follicular adenomas, and four Hurthle cell adenomas), and 91 cases malignant(72 papillary carcinomas, 16 follicular carcinomas, one medullary carcinoma, one anaplastic carcinoma, and one granular cell tumor). After excluding 19 unsatisfactory cases, 63 were misdiagnosed. They included 17 benign(three thyroidites and 14 adenomatous hyperplasias), 27 suspicious(10 follicular adenomas, four Hurthle cell adenomas, and seven follicular carcinomas), and 19 malignant(16 papillary carcinoma, one medullary carcinoma, one anaplastic carcinoma. and one granular cell tumor) lesions. The accuracy rates in the benign, suspicious, and malignant categories were 54.9%, 49.8%, & 92.8%, respectively. The cytological pitfalls were as follows: (1) background, (2) crowded follicular cell clusters indistinguishable between follicular neoplasia and adenomatous hyperplasia, (3) papillary structure, irregular nuclear membrane and pleomorphism mimicking those of papillary carcinoma, (4) indistinct eosinophilia in follicular epithelial cells, (5) unusual cellular components not commonly seen in FNACS of the thyroid.

  • PDF

Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases

  • Jung, Jong-Myung;Kim, Sohee;Joo, Jungnam;Shin, Kyung Hwan;Gwak, Ho-Shin;Lee, Seung Hoon
    • Journal of Korean Neurosurgical Society
    • /
    • 제52권3호
    • /
    • pp.193-199
    • /
    • 2012
  • Objective : The objective of study is to evaluate the incidence of leptomeningeal carcinomatosis (LMC) in breast cancer patients with parenchymal brain metastases (PBM) and clinical risk factors for the development of LMC. Methods : We retrospectively analyzed 27 patients who had undergone surgical resection (SR) and 156 patients with whole brain radiation therapy (WBRT) as an initial treatment for their PBM from breast cancer in our institution and compared the difference of incidence of LMC according to clinical factors. The diagnosis of LMC was made by cerebrospinal fluid cytology and/or magnetic resonance imaging. Results : A total of 27 patients (14%) in the study population developed LMC at a median of 6.0 months (range, 1.0-50). Ten of 27 patients (37%) developed LMC after SR, whereas 17 of 156 (11%) patients who received WBRT were diagnosed with LMC after the index procedure. The incidence of LMC was significantly higher in the SR group compared with the WBRT group and the hazard ratio was 2.95 (95% confidence interval; 1.33-6.54, p<0.01). Three additional factors were identified in the multivariable analysis : the younger age group (<40 years old), the progressing systemic disease showed significantly increased incidence of LMC, whereas the adjuvant chemotherapy reduce the incidence. Conclusion : There is an increased risk of LMC after SR for PBM from breast cancer compared with WBRT. The young age (<40) and systemic burden of cancer in terms of progressing systemic disease without adjuvant chemotherapy could be additional risk factors for the development of LMC.